The global oral microbiome products market was valued at USD 1,350.0 million in 2025 and is projected to reach USD 3,611.1 million by 2033, expanding at a CAGR of 13.1% from 2026 to 2033.
The global oral microbiome products market was valued at USD 1,350.0 million in 2025 and is projected to reach USD 3,611.1 million by 2033, expanding at a CAGR of 13.1% from 2026 to 2033. The market is witnessing steady growth due to increasing awareness of the strong link between oral health and overall systemic health, driving demand for preventive and microbiome-focused oral care solutions.
Consumers and healthcare professionals are increasingly recognizing that imbalance in oral bacteria is associated not only with dental conditions such as cavities, gum disease, and halitosis, but also with systemic diseases including diabetes, cardiovascular disorders, and respiratory infections. For instance, according to the International Diabetes Federation Diabetes Atlas (2025), 11.1% of adults (1 in 9) are living with diabetes, with 46% remaining undiagnosed. By 2050, global cases are expected to reach 853 million, representing a 46% increase and highlighting a growing global health burden. This rising prevalence of chronic diseases is further reinforcing the importance of preventive oral care, thereby accelerating the adoption of oral microbiome-based products that support both oral and systemic wellness.
Key Market Trends & Insights
- North America dominated the oral microbiome products market with the largest revenue share of 35.5% in 2025.
The region’s leadership is supported by high consumer awareness regarding preventive oral care, strong presence of key market players, and rapid adoption of probiotic-based oral health products. Additionally, advanced healthcare infrastructure and increasing focus on wellness-oriented dental care are contributing to regional market growth.
- The U.S. oral microbiome products market is expected to grow at a significant CAGR over the forecast period.
Growth in the U.S. is driven by rising demand for natural and science-backed oral care solutions, increasing prevalence of periodontal diseases, and strong innovation in probiotic and synbiotic formulations. Expanding retail availability and e-commerce penetration are further supporting market expansion.
- By formulation type, the probiotics segment led the market with the largest revenue share in 2025.
Probiotic-based formulations are widely adopted due to their ability to restore microbial balance, reduce harmful bacteria, and improve overall oral health outcomes. Growing clinical validation of oral probiotics is further strengthening segment dominance.
- By application, the caries management segment led the market with the largest revenue share in 2025.
The segment’s growth is driven by the high global prevalence of dental caries and increasing adoption of preventive oral care solutions. Oral microbiome products play a key role in reducing cariogenic bacteria and supporting long-term dental health.
- By end-user, the adult segment led the market with the largest revenue share in 2025.
Adults represent the primary consumer base due to higher exposure to lifestyle-related oral health issues and greater adoption of advanced preventive dental care products. Increasing focus on aesthetic appearance and oral hygiene further supports segment dominance.
Download a free sample copy of the Oral Microbiome Products Market report to gain access to detailed insights, market coverage, and study inclusions.
Key Oral Microbiome Products Company Insights
The oral microbiome products market is highly competitive, with leading companies focusing on product innovation, probiotic research, and strategic collaborations to expand their global presence. Market players are actively investing in clinical validation and new formulation development to strengthen consumer trust and product efficacy.
Key Oral Microbiome Products Companies
The following companies have been profiled in the oral microbiome products market study:
- Unilever
- Colgate-Palmolive Company
- Procter & Gamble
- BLIS Technologies
- BioGaia
- Oragenics, Inc
- ProBiora Health
- Lallemand Inc.
- Sunstar Suisse S.A.
- Ostia Sciences Inc
- Revitin
- NatureWise
Recent Developments
- In February 2026, Gutology raised £1.8 million (USD 2.1 million) in funding to accelerate development of its oral care and synbiotic product portfolio. Its Oral Biome+ toothpaste has emerged as a top-selling oral care product on Amazon UK and Planet Organic, reflecting strong consumer demand for microbiome-focused solutions.
- In January 2026, researchers at Fraunhofer developed a toothpaste ingredient that selectively inhibits periodontal disease-causing bacteria while preserving beneficial oral microbiota. The innovation has been commercialized through the spin-off PerioTrap, supporting next-generation targeted oral care formulations.
- In September 2025, BioGaia launched Prodentis FRESH BREATH lozenges, a microbiome-friendly oral probiotic combined with zinc. The product is designed to support long-lasting fresh breath while promoting healthy gums and oral bacterial balance.
- In September 2025, Boka introduced its Probiotic Toothpaste in Citrus Mint and Peppermint Blossom variants, featuring clinically studied probiotics to support oral microbiome health. The launch reflects rising consumer preference for fluoride-free and wellness-oriented oral care products.
Grand View Research offers
- Focused market intelligence reports on specific geographies or high-growth segments.
- Extended forecast timelines for long-term planning.
- Competitor Benchmarking and Supply Chain Analysis
- Inclusion of regulatory and policy assessments.
- Inclusion of custom data models, KPIs, or applications unique to your business
- Specific high-impact Data Decks and Tables to support effective decision making
- And much more…
Looking for a report customized to your requirements? Explore our Custom Research Offering